Eyenovia announced results from a Phase IV study of Mydcombi designed to characterize the lowest deliverable dose for mydriasis (pupil dilation)
Eyenovia, Inc., and Eversana, the pioneer of next-generation commercial services to the global life sciences industry, announced a partnership to help commercialize MydCombi in the United States, if approved.
Mydrane is indicated for cataract surgery to obtain mydriasis and intraocular anaesthesia during the surgical procedure. Mydrane is indicated in adults only.
Mydriasert is indicated: - to obtain pre-operative mydriasis, - or for diagnostic purposes when monotherapy is known to be insufficient.